GSK invests $120 million in next-generation US biopharma plant
11:26 AM | September 27, 2019 | Michael Ravenscroft
Investment is part of nearly $400 million in US manufacturing investment by GSK since 2017.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.